GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1

Hu,Hao; Ye,Lina; Liu,Zhe

doi:10.3892/mmr.2022.12633

GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1

Authors:
- Hao Hu
- Lina Ye
- Zhe Liu
View Affiliations

Affiliations: Department of Endoscopy, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China, Department of Gastroenterology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550001, P.R. China
Published online on: February 8, 2022 https://doi.org/10.3892/mmr.2022.12633
Article Number: 117
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon cancer is associated with high death rates worldwide and poses a serious threat to public health. GINS complex subunit 2 (GINS2) serves a carcinogenic role in many cancers, including gastric adenocarcinoma, ovarian cancer and pancreatic cancer. However, the specific function of GINS2 in the development of colon cancer has not been described in detail. The present study aimed to clarify the role of GINS2 in colon cancer. A Cell Counting Kit‑8 assay, EdU staining, TUNEL and flow cytometry analyses were performed to determine the levels of cell viability, proliferation and apoptosis and to evaluate the cell cycle. Through the analysis of BioGrid, a Protein‑Protein Interaction database, it was hypothesized that protein tyrosine phosphatase 4A1 (PTP4A1) is a protein that might interact with GINS2, which was then validated using a co‑immunoprecipitation assay. mRNA and protein levels were measured using reverse transcription‑quantitative PCR and western blotting, respectively. The results of the present study demonstrated that GINS2 expression levels were increased in colon cancer cells. Furthermore, GINS2 knockdown inhibited the proliferation of colon cancer cells, while the levels of cell cycle arrest and apoptosis were increased. By interacting with PTP4A1, GINS2 promoted the expression of PTP4A1, a novel p53 target. GINS2 knockdown was increased, while PTP4A1 overexpression decreased the protein level of p53. Notably, PTP4A1 overexpression partly reversed the effects of GINS2 downregulation on colon cancer cells. Therefore, the present study demonstrated that GINS2 regulated the proliferation and apoptosis of colon cancer cells through PTP4A1/p53 pathway, highlighting that GINS2 may serve as a novel molecular marker for colon cancer prevention and therapy.

View Figures

View References

1	Chen H, Luo J and Guo J: Development and validation of a five-immune gene prognostic risk model in colon cancer. BMC Cancer. 20:3952020. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
3	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
4	Center MM, Jemal A, Smith RA and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin. 59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
5	Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, et al: Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 116:544–573. 2010. View Article : Google Scholar : PubMed/NCBI
6	Rupnarain C, Dlamini Z, Naicker S and Bhoola K: Colon cancer: Genomics and apoptotic events. Biol Chem. 385:449–464. 2004. View Article : Google Scholar : PubMed/NCBI
7	Cao C, Yan TD, Black D and Morris DL: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 16:2152–2165. 2009. View Article : Google Scholar : PubMed/NCBI
8	Yaghoubi A, Khazaei M, Avan A, Hasanian SM and Soleimanpour S: The bacterial instrument as a promising therapy for colon cancer. Int J Colorectal Dis. 35:595–606. 2020. View Article : Google Scholar : PubMed/NCBI
9	Kubota Y, Takase Y, Komori Y, Hashimoto Y, Arata T, Kamimura Y, Araki H and Takisawa H: A novel ring-like complex of Xenopus proteins essential for the initiation of DNA replication. Genes Dev. 17:1141–1152. 2003. View Article : Google Scholar : PubMed/NCBI
10	MacNeill SA: Structure and function of the GINS complex, a key component of the eukaryotic replisome. Biochem J. 425:489–500. 2010. View Article : Google Scholar : PubMed/NCBI
11	Stamova BS, Apperson M, Walker WL, Tian Y, Xu H, Adamczy P, Zhan X, Liu DZ, Ander BP, Liao IH, et al: Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics. 2:492009. View Article : Google Scholar : PubMed/NCBI
12	Peng L, Song Z, Chen D, Linghu R, Wang Y, Zhang X, Kou X, Yang J and Jiao S: GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer. Biomed Pharmacother. 84:1568–1574. 2016. View Article : Google Scholar : PubMed/NCBI
13	Yan T, Liang W, Jiang E, Ye A, Wu Q and Xi M: GINS2 regulates cell proliferation and apoptosis in human epithelial ovarian cancer. Oncol Lett. 16:2591–2598. 2018.PubMed/NCBI
14	Wei HB, Wen JZ, Wei B, Han XY and Zhang S: Expression and clinical significance of GINS complex in colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 14:443–447. 2011.(In Chinese). PubMed/NCBI
15	Kabir MF, Mohd Ali J and Haji Hashim O: Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with Melicope ptelefolia leaf extract reveals transcriptome profiles exhibiting anticancer activity. PeerJ. 6:e52032018. View Article : Google Scholar : PubMed/NCBI
16	Achiwa H and Lazo JS: PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res. 67:643–650. 2007. View Article : Google Scholar : PubMed/NCBI
17	Wang J, Kirby CE and Herbst R: The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. J Biol Chem. 277:46659–46668. 2002. View Article : Google Scholar : PubMed/NCBI
18	Liu LZ, He YZ, Dong PP, Ma LJ, Wang ZC, Liu XY, Duan M, Yang LX, Shi JY, Zhou J, et al: Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. Oncotarget. 7:75210–75220. 2016. View Article : Google Scholar : PubMed/NCBI
19	Wang Y, Li ZF, He J and Li YL, Zhu GB, Zhang LH and Li YL: Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis. 22:1179–1184. 2007. View Article : Google Scholar : PubMed/NCBI
20	Chi F, Wang Z, Li Y and Chang N: Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer. Biosci Rep. 40:BSR201939492020. View Article : Google Scholar : PubMed/NCBI
21	Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J, Han YM, Kim IC and Yoo OJ: New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53. Oncogene. 28:545–554. 2009. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Kang YH, Galal WC, Farina A, Tappin I and Hurwitz J: Properties of the human Cdc45/Mcm2-7/GINS helicase complex and its action with DNA polymerase epsilon in rolling circle DNA synthesis. Proc Natl Acad Sci USA. 109:6042–6047. 2012. View Article : Google Scholar : PubMed/NCBI
24	Zhang X, Zhong L, Liu BZ, Gao YJ, Gao YM and Hu XX: Effect of GINS2 on proliferation and apoptosis in leukemic cell line. Int J Med Sci. 10:1795–1804. 2013. View Article : Google Scholar : PubMed/NCBI
25	Schwartz GK and Shah MA: Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol. 23:9408–9421. 2005. View Article : Google Scholar : PubMed/NCBI
26	Swanton C: Cell-cycle targeted therapies. Lancet Oncol. 5:27–36. 2004. View Article : Google Scholar : PubMed/NCBI
27	Hydbring P, Malumbres M and Sicinski P: Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
28	Tchakarska G and Sola B: The double dealing of cyclin D1. Cell Cycle. 19:163–178. 2020. View Article : Google Scholar : PubMed/NCBI
29	Karimian A, Ahmadi Y and Yousefi B: Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 42:63–71. 2016. View Article : Google Scholar : PubMed/NCBI
30	Kerr JF: History of the events leading to the formulation of the apoptosis concept. Toxicology. 181-182:471–474. 2002. View Article : Google Scholar : PubMed/NCBI
31	Chen M, Wu W, Liu D, Lv Y, Deng H, Gao S, Gu Y, Huang M, Guo X, Liu B, et al: Evolution and Structure of API5 and Its Roles in Anti-Apoptosis. Protein Pept Lett. 28:612–622. 2021. View Article : Google Scholar : PubMed/NCBI
32	Sun D, Zong Y, Cheng J, Li Z, Xing L and Yu J: GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathway. J Cancer. 12:99–110. 2021. View Article : Google Scholar : PubMed/NCBI
33	Hao YQ, Liu KW, Zhang X, Kang SX, Zhang K, Han W, Li L and Li ZH: GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells. Mol Cell Biochem. 476:1455–1465. 2021. View Article : Google Scholar : PubMed/NCBI
34	Zhang M, He S, Ma X, Ye Y, Wang G, Zhuang J, Song Y and Xia W: GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway. J Cancer. 11:4662–4670. 2020. View Article : Google Scholar : PubMed/NCBI
35	Wang T, Shi X, Wang Z, Liu X, Zhang G, Zhu Q, Mi L and Wang R: Overexpression of PTP4A1 is associated with poor overall survival in non-small cell lung cancer. Int J Clin Exp Pathol. 11:3583–3590. 2018.PubMed/NCBI
36	Li X, Ma N, Zhang Y, Wei H, Zhang H, Pang X, Li X, Wu D, Wang D, Yang Z and Zhang S: Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1/ERK1/2 pathway. Cell Death Dis. 11:3992020. View Article : Google Scholar : PubMed/NCBI
37	Kress M, May E, Cassingena R and May P: Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J Virol. 31:472–483. 1979. View Article : Google Scholar : PubMed/NCBI
38	Lane D and Levine A: p53 Research: The past thirty years and the next thirty years. Cold Spring Harb Perspect Biol. 2:a0008932010. View Article : Google Scholar : PubMed/NCBI
39	Levav-Cohen Y, Goldberg Z, Tan KH, Alsheich-Bartok O, Zuckerman V, Haupt S and Haupt Y: The p53-Mdm2 loop: A critical juncture of stress response. Subcell Biochem. 85:161–186. 2014. View Article : Google Scholar : PubMed/NCBI
40	Lee YS, Yoon S, Park MS, Kim JH, Lee JH and Song CW: Influence of p53 expression on sensitivity of cancer cells to bleomycin. J Biochem Mol Toxicol. 24:260–269. 2010. View Article : Google Scholar : PubMed/NCBI
41	Takahashi Y, Bucana CD, Cleary KR and Ellis LM: p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer. 79:34–38. 1998. View Article : Google Scholar : PubMed/NCBI